Candida Clinical Trial - An Open-Label Study of the Safety &

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection

Subjects will be stratified by weight to receive one of two doses of study drug ;

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04874441` - Candida PCR Diagnosis Strategy in Patients From Intensive Care Units	N/A
Recruiting	`NCT00697944` - Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients	Phase 4
Completed	`NCT00109525` - Early Diagnosis of Candidiasis in Premature Infants
Completed	`NCT05614726` - A Probiotic Blend Reduces Gastrointestinal Symptoms and Positively Impacts Microbiota Modulation in a Randomized Study	N/A
Completed	`NCT01077336` - Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility	N/A
Completed	`NCT00366223` - Changing Patterns of Candida Infections in Urban Medical Centers
Completed	`NCT03212729` - Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study	N/A
Completed	`NCT00058682` - Anidulafungin Versus Fluconazole in the Treatment of Candidemia	Phase 3